Immune boosting Sulfodyne from Ingood by Olga
advertisement

« Previous article
C-Label Certificatio...
Next article »
GoWell® Tasty Pr...

23rd January 2025  Content supplied by: Onego Bio

Onego Bio Submits Formal GRAS Notification to the FDA for Bioalbumen®


  • Bioalbumen® is the first egg protein with an identical amino acid sequence to natural ovalbumin, created outside the poultry supply chain.
  • The production process reduces greenhouse gas emissions by 89%, land use by 95%, and water consumption by 87% compared to conventional egg production.
  • Designed as a drop-in solution for various food applications, including baked goods, confectionery, pasta, and ready-made meals.

Onego Bio, a Finnish-U.S. food ingredient company, announced the submission of its Generally Recognized as Safe (GRAS) notification to the U.S. Food and Drug Administration (FDA) for its non-animal ovalbumin, produced through precision fermentation using Trichoderma reesei, and branded as Bioalbumen®. This milestone marks a critical step toward bringing the first non-animal egg protein with an amino acid sequence identical to the natural protein for the global food market.

Ovalbumin, the primary protein found in egg white, is known for its exceptional nutritional, functional, and performance properties. Onego Bio's breakthrough Bioalbumen® offers a sustainable solution, leveraging precision fermentation to produce ovalbumin outside of the poultry supply chain. This ingredient was created to address supply chain challenges of the $300B global egg market.  

Our GRAS filing marks a significant milestone for Onego Bio, reinforcing our commitment to building a more resilient supply chain and sustainable food system” said Maija Itkonen, CEO of Onego Bio. “By supplementing traditional agricultural inputs, we can help alleviate future supply chain risks and price fluctuations and provide significant benefits to human health and safety and the environment."  

The GRAS notification process is essential in demonstrating that Onego Bio's Bioalbumen® complies with the FDA's safety standards for its intended uses. It is designed as a drop-in solution across various applications where eggs are needed, including baked goods, confectionery, pasta, and ready-made meals.  

By using fermentation to produce Bioalbumen®, Onego Bio offers a scalable and environmentally friendly solution that reduces greenhouse gas emissions by 89%, land use by 95%, and water consumption by 87% compared to conventional egg production. This safeguards against the rising threat of Avian Influenza on food security and public health, strengthening food security and supply chains in the U.S.  

Visit Onego Bio for more or Request Information below.


    

Tags:

Date Published: 23rd January 2025

Source article link: View


View full company details


Related news